News Channels

20 Mar 2018 Arena Pharmaceuticals Reports Positive Phase 2 Results from the OASIS Trial for Etrasimod in Patients with Ulcerative Colitis
20 Mar 2018 U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) in Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
20 Mar 2018 Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies
20 Mar 2018 Phase III IMpower131 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Reduced The Risk of Disease Worsening or Death in the Initial Treatment of People With a Type of Advanced Squamous Lung Cancer
20 Mar 2018 AJ Vaccines successfully completes two phase III trials of its new low-dose IPV-Al vaccine
19 Mar 2018 Velicept Therapeutics Initiates First of Two Phase 2b Dose-Ranging Studies of Solabegron in Patients with Overactive Bladder (OAB); Finalizes Novel, Once Daily Formulation; and Receives U.S. Patent Covering OAB
19 Mar 2018 EYLEA® (aflibercept) Injection Demonstrates Positive Topline Results in Phase 3 Non-Proliferative Diabetic Retinopathy Trial
19 Mar 2018 Heron Announces Positive Topline Results From Pivotal Phase 3 Clinical Trials of HTX-011 in Bunionectomy and Hernia Repair
19 Mar 2018 SELLAS Life Sciences’ Phase 2 Results for Galinpepimut-S in High-Risk Multiple Myeloma Presented at European Society for Blood and Marrow Transplantation Meeting
19 Mar 2018 Semaglutide injection phase 2 data presented at ENDO demonstrated significant weight loss in adults with obesity
19 Mar 2018 Forendo Pharma receives €3 million loan from Business Finland to develop novel treatments for endometriosis
19 Mar 2018 eTheRNA Completes Enrolment of Low Dose Cohort for Phase 1b Study of TriMix mRNA-based Cancer Specific Immunotherapy (ECI-006) in Melanoma
19 Mar 2018 Valneva Reports Positive Phase I Interim Results for Its Lyme Vaccine Candidate VLA15
19 Mar 2018 Elthera Announces Positive Preclinical Proof of Concept (POC) Studies and Start of New Financing Round
19 Mar 2018 Mundipharma expands biosimilar portfolio with exclusive partnership deal across seven European countries for trastuzumab biosimilar, Herzuma®
17 Mar 2018 FDA Approves Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
16 Mar 2018 Cellular Biomedicine Group Announces Positive 48-Week Clinical Data of AlloJoin™ Human Adipose-Derived Mesenchymal Progenitor Cell (haMPC) Knee Osteoarthritis (KOA) China Phase I Trial
16 Mar 2018 Bavarian Nordic Announces Partnership with U.S. Department of Defense to Combat Equine Encephalitis Virus
16 Mar 2018 Q Biomed Inc. announces FDA filing for approval of a new manufacturing facility for non-opioid Strontium Chloride SR89 Injection USP for relief of cancer bone pain
16 Mar 2018 Lundbeck to acquire Prexton Therapeutics in a deal valued at up to €905 million

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing